Results 181 to 190 of about 1,329,384 (354)

Boswellia oropedionis (Burseraceae) sp. nov., a frankincense tree from Socotra, and notes on B. ameero and B. bullata

open access: yesNordic Journal of Botany, EarlyView.
The new species Boswellia oropedionis Thulin and M.H.Weber is described, illustrated by photographs and mapped. This tree is only known from a small population growing on level limestone on the Qatariyah plateau in southern Socotra and is the twelfth endemic species of Boswellia from the Socotra archipelago. It differs from B.
Mats Thulin   +2 more
wiley   +1 more source

Taxonomy, phylogeny and identification of Botryosphaeriaceae associated with pome and stone fruit trees in South Africa and other regions of the world [PDF]

open access: green, 2006
Bernard Slippers   +5 more
openalex   +1 more source

Euphorbia balsamifera subsp. adenensis (Euphorbiaceae) new to Socotra and notes on its taxonomy

open access: yesNordic Journal of Botany, EarlyView.
Euphorbia balsamifera Aiton has been treated since 1965 as a disjunct species with two subspecies, subsp. balsamifera in the Canary Islands (Spain) and adjacent parts of northwestern Africa, and subsp. adenensis (Deflers) P.R.O.Bally in southwestern Asia and northeastern tropical Africa. However, in 2021, E.
Mats Thulin   +2 more
wiley   +1 more source

Passiflora quimiana, a new species from the Cordillera del Cóndor: Ecuador's far‐flung frontier

open access: yesNordic Journal of Botany, EarlyView.
A new species of Passiflora subgenus Decaloba, supersect. Decaloba, from the Cordillera del Cóndor in Ecuador, is described and illustrated, with its morphological similarities to other species being discussed in this paper. Passiflora quimiana exhibits the unique combination of narrow ovate to long‐oval leaves and small foliaceous bracts ...
J. R. Kuethe   +4 more
wiley   +1 more source

Nutritional priorities to support GLP‐1 therapy for obesity: A joint Advisory from the American College of Lifestyle Medicine, the American Society for Nutrition, the Obesity Medicine Association, and The Obesity Society

open access: yesObesity, EarlyView.
Abstract Background Glucagon‐like peptide 1 receptor agonists and combination medications (hereafter collectively referred to as GLP‐1s) are shifting the treatment landscape for obesity. However, real‐world challenges and limited clinician and public knowledge on nutritional and lifestyle interventions can limit GLP‐1 efficacy, equitable results, and ...
Dariush Mozaffarian   +17 more
wiley   +1 more source

Home - About - Disclaimer - Privacy